Natriumchlorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumchlorid Fresenius Kabi, is an intravenous electrolyte solution presented as an injection solution for IV use. It restores extracellular sodium and chloride balance and provides isotonic fluid volume for patients requiring fluid replacement and electrolyte replenishment. It is manufactured in the European Union under strict pharmacopeial standards and is indicated for a broad range of clinical settings, including surgery and critical care.

GNH USA supplies Natriumchlorid Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide, ensuring quality and regulatory compliance.

Natriumchlorid Fresenius Kabi is used in clinical situations that require restoration of extracellular fluid volume and electrolyte balance.

Fluid replacement: restores intravascular volume in patients with dehydration or blood loss. Electrolyte replenishment: corrects sodium and chloride deficits in hyponatremia. Surgical irrigation: provides isotonic solution for intra‑operative flushing and wound care. Critical care: maintains hemodynamic stability in intensive care unit patients.

Intravenous sodium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Transient hypernatremia: temporary rise in serum sodium levels. - Fluid overload: excess extracellular fluid leading to mild edema.

Serious or Rare Side Effects: - Severe hypernatremia: marked increase in serum sodium causing neurological symptoms. - Anaphylactoid reaction: rare hypersensitivity with rash, bronchospasm, or hypotension. - Electrolyte imbalance: severe shifts in potassium or calcium secondary to rapid infusion. - Cardiac arrhythmia: abnormal heart rhythm associated with electrolyte disturbances.

When using Natriumchlorid Fresenius Kabi, clinicians should observe specific safety measures to minimize risks.

Assess volume status: evaluate patient’s fluid balance before administration. Monitor electrolytes: check serum sodium and chloride levels during therapy. Adjust infusion rate: tailor speed to patient’s cardiac and renal function. Avoid rapid large-volume bolus in heart failure: may precipitate pulmonary edema. Store below 25°C: keep in original container, protect from moisture and light.

Sodium chloride infusion can interact with other agents, influencing electrolyte balance or fluid status.

Major Interactions (Avoid): - Hypertonic glucose solutions: concurrent use may cause severe hypernatremia. - Potassium chloride IV: combined high electrolyte load can lead to cardiac arrhythmias. - Diuretics (loop, thiazide): may exacerbate electrolyte shifts if not monitored.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance risk of hyperkalemia when sodium balance changes. - Corticosteroids: can increase sodium retention, requiring careful volume assessment. - Blood products (packed RBCs): concurrent infusion may affect overall fluid volume.